Iteyes signs three-party MOU, aiming to develop AI-based cancer diagnosis solution
Predicted impact: Low
Three-party MOU for AI cancer diagnosis; no contract value or revenue share given.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.